ECSP056059A - Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas - Google Patents
Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidasInfo
- Publication number
- ECSP056059A ECSP056059A EC2005006059A ECSP056059A ECSP056059A EC SP056059 A ECSP056059 A EC SP056059A EC 2005006059 A EC2005006059 A EC 2005006059A EC SP056059 A ECSP056059 A EC SP056059A EC SP056059 A ECSP056059 A EC SP056059A
- Authority
- EC
- Ecuador
- Prior art keywords
- quinolin
- substituted
- acetyl
- hydroxy
- oxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
La invención se refiere a un proceso para preparar oxi-(1H)-quinolin-2-onas 5-(a-haloacetil)-8-sustituidas. El proceso involucra: (i) hacer reaccionar (a) 8-hidroxi-(1H)-quinolin-2-ona con un agente de acilación y un ácido de Lewis para formar 5-acetil-8-hidroxi-(1H)-quinolin-2-ona; o (b) 8-hidroxi-(1H)-quinolin-2-ona con un agente de acilación para formar 8-acetoxi-(1H)-quinolin-2-ona, y tratar, in situ, la 8-acetoxi-(1H)-quinolin-2-ona con un ácido de Lewis para formar la 5-acetil-8-hidroxi-(1H)-quinolin-2-ona; o (c) 8-acetoxi-(1H)-quinolin-2-ona con un ácido de Lewis para formar 5-acetil-8-hidroxi-(1H)-quinolin-2-ona; (ii) hacer reaccionar la 5-acetil-8-hidroxi-(1H)-quinolin-2-ona preparada en el Paso (i) con un compuesto que tiene la Fórmula RL en la presencia de una base y un solvente para formar la oxi-(1H)-quinolin-2-ona 5-acetil-8-sustituida, en donde R es un grupo protector y L es un grupo saliente, y (iii) hacer reaccionar la oxi-(1H)-quinolin-2-ona 5-acetil-8-sustituida con un agente de halogenación en la presencia de un solvente, para formar una oxi-(1H)-quinolin-2-ona 5-(a-haloacetil)-8-sustituida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45972403P | 2003-04-02 | 2003-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP056059A true ECSP056059A (es) | 2006-01-27 |
Family
ID=33131902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2005006059A ECSP056059A (es) | 2003-04-02 | 2005-09-29 | Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7605267B2 (es) |
| EP (1) | EP1613599B8 (es) |
| JP (1) | JP4726778B2 (es) |
| KR (1) | KR101073740B1 (es) |
| CN (1) | CN1774423A (es) |
| AR (2) | AR043825A1 (es) |
| AT (1) | ATE491690T1 (es) |
| AU (1) | AU2004226212B2 (es) |
| BR (1) | BRPI0409154B1 (es) |
| CA (1) | CA2520990C (es) |
| CL (1) | CL2004000706A1 (es) |
| CO (1) | CO5700779A2 (es) |
| CY (1) | CY1111515T1 (es) |
| DE (1) | DE602004030553D1 (es) |
| DK (1) | DK1613599T3 (es) |
| EC (1) | ECSP056059A (es) |
| ES (1) | ES2358193T3 (es) |
| HK (1) | HK1086833A1 (es) |
| HR (1) | HRP20110184T1 (es) |
| IL (1) | IL171053A (es) |
| IS (1) | IS2800B (es) |
| MA (1) | MA27761A1 (es) |
| MX (1) | MXPA05010616A (es) |
| MY (1) | MY141871A (es) |
| NO (1) | NO331980B1 (es) |
| NZ (1) | NZ542623A (es) |
| PE (2) | PE20100399A1 (es) |
| PL (1) | PL1613599T3 (es) |
| PT (1) | PT1613599E (es) |
| RU (1) | RU2339621C2 (es) |
| SI (1) | SI1613599T1 (es) |
| TN (1) | TNSN05245A1 (es) |
| TW (1) | TWI324151B (es) |
| WO (1) | WO2004087668A1 (es) |
| ZA (1) | ZA200507603B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0413960D0 (en) * | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| PT2044025E (pt) | 2006-06-30 | 2012-12-17 | Novartis Ag | Derivados de quinolinona e suas composições farmacêuticas |
| WO2013132514A2 (en) * | 2012-03-09 | 2013-09-12 | Rao Davuluri Ramamohan | A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one |
| CN102633717B (zh) * | 2012-03-30 | 2013-11-20 | 西南大学 | N-乙酰-喹啉-2(1h)酮类化合物及其制备方法和应用 |
| CN104379566B (zh) * | 2012-07-11 | 2016-08-24 | 上海威智医药科技有限公司 | 茚达特罗中间体及茚达特罗的合成方法 |
| CZ306252B6 (cs) | 2013-03-15 | 2016-10-26 | Zentiva, K.S. | Způsob přípravy 5-[(R)-2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1H)-chinolin-2-onu (indacaterolu) |
| ES2815123T3 (es) | 2014-01-09 | 2021-03-29 | Davuluri Ramamohan Rao | Proceso novedoso para la preparación de indacaterol o sus sales aceptables farmacéuticamente |
| CN105693603B (zh) * | 2014-11-24 | 2019-11-29 | 上海医药工业研究院 | 改良的马来酸茚达特罗制备工艺 |
| CN107531636B (zh) * | 2015-04-09 | 2022-11-25 | 正大天晴药业集团股份有限公司 | 茚达特罗或其盐的制备方法 |
| CN107868045A (zh) * | 2016-09-28 | 2018-04-03 | 四川海思科制药有限公司 | 一种茚达特罗中间体的制备方法 |
| CN108264483A (zh) * | 2016-12-31 | 2018-07-10 | 天津金耀集团有限公司 | 一种马来酸茚达特罗的制备方法 |
| CN109721534B (zh) * | 2018-09-25 | 2022-05-20 | 四川海思科制药有限公司 | 一种马来酸茚达特罗中间体及其制备方法和用途 |
| CN114751857A (zh) * | 2022-04-29 | 2022-07-15 | 梯尔希（南京）药物研发有限公司 | 一种茚达特罗杂质的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS539228B2 (es) * | 1974-01-31 | 1978-04-04 | ||
| CA1164459A (en) | 1980-11-11 | 1984-03-27 | Yung-Hsiung Yang | Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives |
| JPS5896022A (ja) * | 1981-11-30 | 1983-06-07 | Otsuka Pharmaceut Co Ltd | 強心剤 |
| ES8403457A1 (es) * | 1983-01-28 | 1984-03-16 | Espanola Farma Therapeut | Procedimiento para la obtencion de un compuesto derivado de la 2-quinolinona. |
| ES8605239A1 (es) * | 1985-12-04 | 1986-03-16 | Astur Pharma | Un procedimiento para la preparacion de quinolonas sustitui-das |
| GB9405019D0 (en) | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| GB0029562D0 (en) * | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
| US6653323B2 (en) * | 2001-11-13 | 2003-11-25 | Theravance, Inc. | Aryl aniline β2 adrenergic receptor agonists |
| TWI324150B (en) * | 2003-02-28 | 2010-05-01 | Novartis Ag | Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt |
-
2004
- 2004-03-31 TW TW093108942A patent/TWI324151B/zh not_active IP Right Cessation
- 2004-03-31 PE PE2010000225A patent/PE20100399A1/es not_active Application Discontinuation
- 2004-03-31 PE PE2004000341A patent/PE20050211A1/es not_active Application Discontinuation
- 2004-04-01 CA CA2520990A patent/CA2520990C/en not_active Expired - Lifetime
- 2004-04-01 DE DE602004030553T patent/DE602004030553D1/de not_active Expired - Lifetime
- 2004-04-01 DK DK04725035.2T patent/DK1613599T3/da active
- 2004-04-01 ES ES04725035T patent/ES2358193T3/es not_active Expired - Lifetime
- 2004-04-01 WO PCT/EP2004/003479 patent/WO2004087668A1/en active Application Filing
- 2004-04-01 US US10/550,621 patent/US7605267B2/en active Active
- 2004-04-01 RU RU2005133664/04A patent/RU2339621C2/ru active
- 2004-04-01 EP EP04725035A patent/EP1613599B8/en not_active Expired - Lifetime
- 2004-04-01 PL PL04725035T patent/PL1613599T3/pl unknown
- 2004-04-01 BR BRPI0409154-0B1A patent/BRPI0409154B1/pt not_active IP Right Cessation
- 2004-04-01 MY MYPI20041213A patent/MY141871A/en unknown
- 2004-04-01 CL CL200400706A patent/CL2004000706A1/es unknown
- 2004-04-01 CN CNA2004800089560A patent/CN1774423A/zh active Pending
- 2004-04-01 SI SI200431618T patent/SI1613599T1/sl unknown
- 2004-04-01 PT PT04725035T patent/PT1613599E/pt unknown
- 2004-04-01 AT AT04725035T patent/ATE491690T1/de active
- 2004-04-01 MX MXPA05010616A patent/MXPA05010616A/es active IP Right Grant
- 2004-04-01 AR ARP040101105A patent/AR043825A1/es not_active Application Discontinuation
- 2004-04-01 JP JP2006504953A patent/JP4726778B2/ja not_active Expired - Lifetime
- 2004-04-01 NZ NZ542623A patent/NZ542623A/en not_active IP Right Cessation
- 2004-04-01 AU AU2004226212A patent/AU2004226212B2/en not_active Expired
-
2005
- 2005-09-20 ZA ZA200507603A patent/ZA200507603B/en unknown
- 2005-09-22 IL IL171053A patent/IL171053A/en active IP Right Grant
- 2005-09-29 EC EC2005006059A patent/ECSP056059A/es unknown
- 2005-09-30 TN TNP2005000245A patent/TNSN05245A1/en unknown
- 2005-09-30 KR KR1020057018750A patent/KR101073740B1/ko active IP Right Grant
- 2005-10-11 MA MA28545A patent/MA27761A1/fr unknown
- 2005-10-12 CO CO05104250A patent/CO5700779A2/es active IP Right Grant
- 2005-10-27 IS IS8095A patent/IS2800B/is unknown
- 2005-11-01 NO NO20055099A patent/NO331980B1/no unknown
-
2006
- 2006-06-16 HK HK06106919.9A patent/HK1086833A1/xx not_active IP Right Cessation
-
2011
- 2011-03-14 CY CY20111100284T patent/CY1111515T1/el unknown
- 2011-03-14 HR HR20110184T patent/HRP20110184T1/hr unknown
-
2016
- 2016-01-25 AR ARP160100188A patent/AR103508A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056059A (es) | Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas | |
| BR0113989A (pt) | Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos | |
| CY1108081T1 (el) | Αρυλο-και ετεροαρυλο υποκατεστημενες τετραυδροισοκινολινες και χρησις αυτων προς αποκλεισμον επαναπροσληψεως νορεπινεφρινης ντοπαμινης και σεροτονινης | |
| BR0112786A (pt) | Inibidores de inflamação não-esteroidais | |
| BR0308967A (pt) | Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação | |
| BR0206433A (pt) | Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto | |
| BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
| SE0102616D0 (sv) | Novel compounds | |
| BRPI0514841A (pt) | inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores | |
| PA8676301A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
| PT1305286E (pt) | Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento | |
| AR011116A1 (es) | Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene | |
| AR056456A1 (es) | Procedimiento para la preparacion de betamiméticos | |
| BRPI0113162B8 (pt) | compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| AR051667A1 (es) | Uso de polisilazanos para recubrir tiras metalicas | |
| CO5601045A2 (es) | Procedimiento para la fabricacion de compuestos organicos | |
| ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
| SE0003476D0 (sv) | Compounds | |
| BRPI0411308A (pt) | composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
| BR0115276A (pt) | Composições farmacêuticas, uso de pelo menos um dos compostos, compostos, e, processo para a preparação de uma composição farmacêutica | |
| AR039719A1 (es) | Derivados de ftalamida | |
| UY27133A1 (es) | 11beta-halogenesteroides, su obtención y uso para la preparación de medicamentos y preparados farmacéuticos que contienen 11 beta-halogenesteroides | |
| ES2182317T3 (es) | Produccion de compuestos de avermectina. | |
| MXPA03002937A (es) | Benzimidazoles n-alcoxialquil-substituidos y su uso como agentes contra protozoos parasitantes. |